Long-term treatment with chemotherapeutic agents may lead to an increase in the expression of ABCG2 in cancer cells, causing an increase in the efflux and decrease in the intracellular accumulation of its substrates, thereby causing MDR [21,22,23,24]. Here, ABCG2 is linked to cancer.